Feature: BioPharmica progresses toward cancer treatment
Friday, August 28, 2009 - 23:55
in Health & Medicine
A new generation anti-mitotic drug is being tested for its ability to inhibit tumour growth with minimal side effects.
A new generation anti-mitotic drug is being tested for its ability to inhibit tumour growth with minimal side effects.
